Corrigendum to "Assessing the Cost-utility of Preferentially Administering Heplisav-B Vaccine to Certain Populations" [Vaccine 38(51) (2020) 8206-8215]
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.